TR200002921T2 - Yarı-Sentetik ekteinasidinler - Google Patents

Yarı-Sentetik ekteinasidinler

Info

Publication number
TR200002921T2
TR200002921T2 TR2000/02921T TR200002921T TR200002921T2 TR 200002921 T2 TR200002921 T2 TR 200002921T2 TR 2000/02921 T TR2000/02921 T TR 2000/02921T TR 200002921 T TR200002921 T TR 200002921T TR 200002921 T2 TR200002921 T2 TR 200002921T2
Authority
TR
Turkey
Prior art keywords
synthetic
semi
ekteinacids
acidacid
boc
Prior art date
Application number
TR2000/02921T
Other languages
English (en)
Inventor
Lloyd Rinehart Kenneth
J Morales Jose
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of TR200002921T2 publication Critical patent/TR200002921T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

Bu bulus, burada Et 757,Boc-Et 729, Iso-Et 743,Et875, ve Et 1560 olarak belirlenen birkaç yeni hazirlanmis yari-sentetik ekteinasidin (Et) türüyle ilgilidir. Bu bilesimlerin fiziksel özellikleri, hazirlanmalari ve biyo-aktiviteleri de açiklanmistir.
TR2000/02921T 1998-04-06 1999-04-05 Yarı-Sentetik ekteinasidinler TR200002921T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06

Publications (1)

Publication Number Publication Date
TR200002921T2 true TR200002921T2 (tr) 2001-02-21

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02921T TR200002921T2 (tr) 1998-04-06 1999-04-05 Yarı-Sentetik ekteinasidinler

Country Status (28)

Country Link
US (1) US6124293A (tr)
EP (2) EP1876180A3 (tr)
JP (1) JP4443043B2 (tr)
KR (1) KR100603219B1 (tr)
CN (1) CN1157189C (tr)
AT (1) ATE370148T1 (tr)
AU (1) AU758100B2 (tr)
BG (1) BG65088B1 (tr)
BR (1) BR9909488B1 (tr)
CA (1) CA2327468C (tr)
CY (1) CY1106988T1 (tr)
CZ (1) CZ301083B6 (tr)
DE (1) DE69936845T2 (tr)
DK (1) DK1067933T3 (tr)
ES (1) ES2292237T3 (tr)
HK (1) HK1033651A1 (tr)
HU (1) HUP0104273A3 (tr)
IL (2) IL138856A0 (tr)
MX (1) MXPA00009840A (tr)
NO (1) NO328147B1 (tr)
NZ (1) NZ507350A (tr)
PL (1) PL196809B1 (tr)
PT (1) PT1067933E (tr)
RU (1) RU2217432C2 (tr)
SK (1) SK285669B6 (tr)
TR (1) TR200002921T2 (tr)
UA (1) UA59439C2 (tr)
WO (1) WO1999051238A1 (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
DE69923965T2 (de) * 1998-05-11 2006-04-06 Pharma Mar, S.A., Tres Cantos Ecteinascidinderivate
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US6686470B2 (en) 2000-01-19 2004-02-03 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
WO2002040477A2 (en) * 2000-11-03 2002-05-23 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
PL361389A1 (en) * 2000-11-06 2004-10-04 Pharma Mar, S.A. Effective antitumour treatments
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
CA2544320A1 (en) * 2003-11-13 2005-06-02 Pharma Mar, S.A.U. Method of treating cancer using a combination comprising et-743 and 5-fluorouracil
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
US20080255132A1 (en) * 2003-11-14 2008-10-16 Eric Rowinsky Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
JP2008505862A (ja) * 2004-07-09 2008-02-28 ファルマ、マール、ソシエダード、アノニマ 予後分子マーカー
CA2583464A1 (en) * 2004-09-29 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
DE602005014380D1 (de) * 2004-10-26 2009-06-18 Ortho Biotech Products L P Pegyliertes liposomales doxorubicin in kombination mit ecteinescidin 743
ES2290844T3 (es) 2004-10-29 2008-02-16 Pharma Mar S.A., Sociedad Unipersonal Composiciones que comprenden ecteinascidinas y un disacarido.
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
US20100267732A1 (en) * 2007-10-19 2010-10-21 Pharma Mar, S.A. Prognostic Molecular Markers for ET-743 Treatment
CN106860870B (zh) 2010-11-12 2020-03-31 法马马有限公司 抗肿瘤生物碱的联合治疗
CN107427512B (zh) * 2016-02-04 2021-10-08 江苏恒瑞医药股份有限公司 一种曲贝替定的可注射胃肠外用药物组合物及其制备方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
US6124293A (en) 2000-09-26
WO1999051238A1 (en) 1999-10-14
PL343439A1 (en) 2001-08-13
RU2217432C2 (ru) 2003-11-27
KR100603219B1 (ko) 2006-07-20
DE69936845D1 (de) 2007-09-27
EP1067933A4 (en) 2002-12-18
IL138856A0 (en) 2001-10-31
EP1876180A3 (en) 2009-12-16
CA2327468C (en) 2008-05-06
CN1304309A (zh) 2001-07-18
AU3471399A (en) 1999-10-25
CN1157189C (zh) 2004-07-14
WO1999051238A9 (en) 2000-01-27
CZ301083B6 (cs) 2009-11-04
JP2002510633A (ja) 2002-04-09
BR9909488B1 (pt) 2011-02-08
NZ507350A (en) 2003-03-28
JP4443043B2 (ja) 2010-03-31
UA59439C2 (uk) 2003-09-15
BG104902A (en) 2001-07-31
HK1033651A1 (en) 2001-09-14
NO20004978L (no) 2000-12-05
SK285669B6 (sk) 2007-06-07
HUP0104273A2 (hu) 2002-03-28
ES2292237T3 (es) 2008-03-01
CY1106988T1 (el) 2012-09-26
PT1067933E (pt) 2007-11-15
DE69936845T2 (de) 2008-05-08
IL138856A (en) 2007-07-24
DK1067933T3 (da) 2007-12-27
MXPA00009840A (es) 2002-04-24
CZ20003650A3 (en) 2001-06-13
CA2327468A1 (en) 1999-10-14
NO20004978D0 (no) 2000-10-03
RU2000128058A (ru) 2004-02-20
AU758100B2 (en) 2003-03-13
HUP0104273A3 (en) 2003-12-29
BG65088B1 (bg) 2007-02-28
PL196809B1 (pl) 2008-02-29
ATE370148T1 (de) 2007-09-15
SK15012000A3 (sk) 2001-08-06
EP1067933A1 (en) 2001-01-17
EP1067933B1 (en) 2007-08-15
NO328147B1 (no) 2009-12-21
BR9909488A (pt) 2000-12-26
EP1876180A2 (en) 2008-01-09
KR20010074474A (ko) 2001-08-04

Similar Documents

Publication Publication Date Title
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
ID23374A (id) Halogenopirimidin
TR199900239T2 (tr)
DE3585294D1 (de) Molekularsiebzusammensetzungen.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
FI931427A (fi) Ny onkofetal gen, genprodukt och anvaendningen daerav
DE3584905D1 (de) Molekularsiebzusammensetzungen.
DE69005438D1 (de) Bernsteinsäureimid-Zusammensetzungen.
DE69016390T2 (de) Nitrierofen.
DE3775170D1 (de) Trockenes abziehbild, dessen unerwuenschte flaechen sich selbststaendig von den bildflaechen trennen.
FI923536A (fi) Foerfarande foer analysering av gasprov, analyseringsanordning, dess anvaendning och en test anlaeggning med den naemnda analyseringsanordningen.
DE69715038D1 (de) Auf (n-phenylacetyl-n-2,6-xylyl)methylalaninat basierte fungizide zusammensetzungen
DE3576488D1 (de) Molekularsieb-zusammensetzungen.
DE69003075T2 (de) Stabilisierungszusammensetzungen.
FR2707297B1 (fr) Mélange silicone autoémulsifiable.
TR199900403T2 (tr) Amorf benzotiofenler, hazirlama yöntemleri ve kullanma yöntemleri.
IL139604A0 (en) Novel peptides
DE69014095T3 (de) Bernsteinsäureimid-Zusammensetzungen.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
RS49662B (sr) Fungicidi
FI905350A0 (fi) Komposition innehaollande maerkta streptokock-antikroppar,testfoerpackning och analysfoerfarande, i vilket den anvaends.
FR2720395B1 (fr) Nouveaux composés de la famille des benzohétérocycles.
DE69020790T2 (de) Organosilicium-Verbindungen.
NO20014937L (no) Naturlige pseudomycinprodukter